Michael Markow, MD | |
2925 Vernon Pl, Suite 100, Cincinnati, OH 45219-2425 | |
(513) 569-1310 | |
Not Available |
Full Name | Michael Markow |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 12 Years |
Location | 2925 Vernon Pl, Cincinnati, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194091892 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 127998 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sunrise Hospital And Medical Center | Las vegas, NV | Hospital |
Henderson Hospital | Henderson, NV | Hospital |
Summerlin Hospital Medical Center | Las vegas, NV | Hospital |
Centennial Hills Hospital Medical Center | Las vegas, NV | Hospital |
Valley Hospital Medical Center | Las vegas, NV | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Laboratory Medicine Consultants Ltd | 4183617533 | 27 |
News Archive
Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.
The American Academy of Physiological Medicine and Dentistry (AAPMD) is leading the charge for an interdisciplinary medical approach to the diagnosis and treatment of sleep and breathing disorders, which research indicates contribute to a range of serious physiological, cognitive, behavioral and performance conditions in children and adults.
Despite the potential of new vaccines to prevent TB, new research shows that the removal of one strain of TB can allow a previously suppressed strain to succeed. Consequently, a vaccination program could result in the proliferation of strains more likely to be, or become, drug resistant, and could even result in an increased prevalence of the disease.
Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.
› Verified 2 days ago
Entity Name | Laboratory Medicine Consultants Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083675169 PECOS PAC ID: 4183617533 Enrollment ID: O20040618000578 |
News Archive
Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.
The American Academy of Physiological Medicine and Dentistry (AAPMD) is leading the charge for an interdisciplinary medical approach to the diagnosis and treatment of sleep and breathing disorders, which research indicates contribute to a range of serious physiological, cognitive, behavioral and performance conditions in children and adults.
Despite the potential of new vaccines to prevent TB, new research shows that the removal of one strain of TB can allow a previously suppressed strain to succeed. Consequently, a vaccination program could result in the proliferation of strains more likely to be, or become, drug resistant, and could even result in an increased prevalence of the disease.
Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Markow, MD 297 W 6th Ave, Unit A, Columbus, OH 43201-3173 Ph: (305) 781-4092 | Michael Markow, MD 2925 Vernon Pl, Suite 100, Cincinnati, OH 45219-2425 Ph: (513) 569-1310 |
News Archive
Pfizer Inc. today released detailed information about how and why the company works with a range of healthcare professionals and researchers to advance patient care and develop lifesaving medicines. The information reflects payments or exchanges of value received by licensed U.S. healthcare professionals who consulted with Pfizer about the development and marketing of new medicines and helped to educate other healthcare professionals about the safe and appropriate use of its products.
The American Academy of Physiological Medicine and Dentistry (AAPMD) is leading the charge for an interdisciplinary medical approach to the diagnosis and treatment of sleep and breathing disorders, which research indicates contribute to a range of serious physiological, cognitive, behavioral and performance conditions in children and adults.
Despite the potential of new vaccines to prevent TB, new research shows that the removal of one strain of TB can allow a previously suppressed strain to succeed. Consequently, a vaccination program could result in the proliferation of strains more likely to be, or become, drug resistant, and could even result in an increased prevalence of the disease.
Just because you can't see something doesn't mean it's not there. Brain tumors are an extremely serious example of this and are not only difficult to treat-both adult and pediatric patients have a five-year survival rate of only 30 percent-but also have even been difficult to image, which could provide important information for deciding next steps in the treatment process.
› Verified 2 days ago
Bruce G Storrs, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-872-1400 | |
Mei Liang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Lab Medicine Building, Cincinnati, OH 45219 Phone: 513-584-3834 Fax: 513-558-2289 | |
Parsa Hodjat, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 3333 Burnet Ave., Ml 1035, Cincinnati, OH 45229 Phone: 513-636-4261 Fax: 513-636-3924 | |
Gregory Retzinger, MD Pathology Medicare: Medicare Enrolled Practice Location: 231 Albert Sabin Way, Department Of Pathology, Cincinnati, OH 45267 Phone: 513-558-4500 Fax: 513-558-2289 | |
Ila N Mehta Iii, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 375 Dixmyth Ave, Cincinnati, OH 45220 Phone: 513-624-4337 | |
Jiang Wang, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-584-1000 Fax: 513-584-3778 | |
Dani S Zander, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 234 Goodman St, Cincinnati, OH 45219 Phone: 513-584-7284 Fax: 513-584-3807 |